Navigation Links
Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
Date:12/20/2007

NEW YORK, Dec. 20 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (ITI), today announced it has initiated a sleep maintenance insomnia (SMI) Phase 2 clinical study using its drug candidate ITI-722. ITI-722 acts predominantly as a selective 5-HT2A receptor antagonist and represents an important new approach to the treatment of SMI. Because of its novel separation of 5-HT2A and dopamine receptor modulatory activities, ITI believes, ITI-722 can be used not only to treat SMI but it may be highly appropriate for the treatment of sleep disorders that accompany neurodegenerative disorders, including Parkinson's disease and other psychiatric disorders.

"The progression of ITI-722 into Phase 2 for SMI represents the advancement of this important new class of therapeutics," stated Sharon Mates, Ph.D., Chairman and Chief Executive Officer of Intra-Cellular Therapies. "This drug candidate has therapeutic potential to treat SMI in the general population, and in other patient populations who have been underserved, particularly peri- and post-menopausal women, and in other disorders where insomnia is a problem, including osteoarthritis, depression, Parkinson's disease and other neurologic and psychiatric disorders."

The Phase 2 program is a multi-center, randomized, double-blind placebo- controlled study in patients with SMI. The primary endpoint is an assessment of objective slow wave sleep using polysomnography (PSG). Secondary endpoints include other objective and subjective measures of SMI and sleep efficiency. Additionally, the study will make an assessment regarding next-day cognitive performance.

ITI-722 is a low-dose formulation of ITI-007, ITI's first-in-class 5-HT2A antagonist/ dopamine receptor protein phosphorylation modulator (DPPM), presently in clinical trials for the treatment of schizophrenia.

About Sleep Maintenance Disorders

From nightmares to insomnia to sleep apnea, sleep disorders disrupt the sleep of millions of peopl
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intra-Cellular Therapies Presents Preclinical Data From Schizophrenia and Sleep Maintenance Programs
2. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
3. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
7. Vital Therapies Announces Presentation of ELAD(R) Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
8. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
9. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015  Pharmaceutical companies and diagnostics companies ... and this is translating into a sizeable ... them. This according to Kalorama Information, a healthcare ... as mass spectrometry, electrophoresis and liquid chromatography ... drug targets and the validation of biomarkers, ...
(Date:5/28/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... H. Mackaness is scheduled to present at the LD ... PT in Los Angeles . ... on the Event Calendar of the Investors section of IRIDEX,s ... will be available shortly after the conclusion of the presentation ...
(Date:5/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/pph6hl/united_states ... "United States Medical Adhesives Market Forecast and Opportunities, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , The market ... States is projected to register 9% ... manufacturers across the US are expanding their production ...
Breaking Medicine Technology:Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3
... ALBUQUERQUE, N.M., June 3, 2011 Rep. Ed Whitfield, ... Representatives that will set federal minimum education and certification ... providing, planning and delivering all medical imaging examinations and ... and Excellence ( CARE ) in Medical Imaging and ...
... Diagnostics Incorporated (NYSE: DGX ), the world,s ... that it is scheduled to speak at the Jefferies ... presentation is scheduled for Monday, June 6, 2011 at ... be webcast live during the conference and will be ...
Cached Medicine Technology:Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 2Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 AMIA Issues ... the management of medical data. , Today AMIA released ... Health Records (EHR). The “ Report of the ... Future Direction of EHRs ” was released in the ... jamia.org and represents an evolutionary approach in ...
(Date:5/29/2015)... The Bill Howe Family of Companies is ... air conditioning and restoration & flood services company. Family-owned and ... commitment to giving back to their community. They have been ... row from the Union Tribune Reader’s Poll, a Healthiest Company ... multi-year recognition as a Best Place to Work as well ...
(Date:5/28/2015)... 2015 On Monday, June 1, KORT, ... 160 Frankfort Road in Shelbyville, Kentucky . Clinic Director, Chad ... well as treat patients , “ Shelbyville is a ... , local clinic to better serve the residents of Shelby ... experience as trouble-free as possible by providing accessible and immediate ...
(Date:5/28/2015)... Sierra Madre, CA (PRWEB) May 28, 2015 ... providing superior outpatient wound center management for a decade with ... a partnership was formed between USC and Wound Care Advantage ... team was recognized for a drop in the ... percent. , Wound healing is a complex undertaking that ...
(Date:5/28/2015)... 2015 Success Strategies for Biosimilars ... **FDAnews Webinar**, June 23, 2015 — 11:00 a.m. ... On June 23, 2015, FDAnews is offering the ... property attorneys from the international law firm Duane ... Approval: A Roadmap to the 351(k) Application Process. ...
Breaking Medicine News(10 mins):Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 2Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 3Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 2Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 3Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3
... educational initiatives between the clinical staff at Fox Chase ... suggest that educational interventions by academic cancer centers can ... hospitals. The study, to be presented at the ... Oncology, looked specifically at the number of lymph nodes ...
... symptoms among breast cancer patients , , THURSDAY, May 14 ... of ginger that many grandmothers are already familiar with, ... were undergoing chemotherapy. , "Ginger at a daily dose ... chemotherapy-related nausea on the first day of chemotherapy, and ...
... Hanger Orthopedic Group Inc. (NYSE: HGR ) will ... 600 after the close of trading on a date to ... TriNet Group, Inc. in a transaction expected to close soon.Standard ... updates on its website: www.standardandpoors.com . Hanger ...
... The ,Help is Here Express, bus tour will be stopping ... various cities in order to help uninsured and financially-struggling Utahans ... or nearly free. With the state,s unemployment rate now hitting ... the Partnership for Prescription Assistance (PPA) bus tour is raising ...
... the FDA,s approval of Prevacid OTC(R) 24HR, The Procter ... http://www.newscom.com/cgi-bin/prnh//NY17325 )"Prilosec OTC(R) ... remedy in the U.S.," said Tim Brown - General ... Gamble built the OTC PPI market and since 2003, ...
... Curt Schilling and Wife Shonda Enter The ALS Association,s Hall of Fame, ... ... The ALS Association has inducted former Major League Baseball pitcher Curt Schilling ... first inductees for their long time support of The Association in the ...
Cached Medicine News:Health News:Educational initiatives improve quality of care delivery 2Health News:Ginger Eases Nausea From Chemo 2Health News:Standard & Poor's Announces Changes to U.S. Index 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 4Health News:P&G Response to FDA Approval of Prevacid OTC(R) 24HR 2Health News:More than $10 Million Raised for the Fight Against Lou Gehrig's Disease 2Health News:More than $10 Million Raised for the Fight Against Lou Gehrig's Disease 3Health News:More than $10 Million Raised for the Fight Against Lou Gehrig's Disease 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a panel mounted system that offers several ... of the heath care professional using the system. ... with a dual action lever that allows the ... an IV pole. Similarly, it features a ...
... Surgical Foam Headrest automatically secures the ... as comfortable as possible. Several center ... for any head size from pediatric ... autoclaved when necessary. From surgical suite ...
... The Multi-Cap system provides patients with ... distance viewing to reading. The ... for distance viewing. The double ... 3x and 4x magnifications. Each ...
Medicine Products: